Shree Ganesh Remedies Ltd announced its unaudited financial results for Q3 FY25 showing a 3% decline in revenue from operations compared to the previous year, with total income down 5%. The company remains focused on strategic expansion and innovation in pharmaceutical intermediates and specialty chemicals.